10 research outputs found
The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy
Full text link3D absorbed dose distribution estimated by Monte Carlo simulation in radionuclide therapy with a monoclonal antibody targeting synovial sarcoma
Get PDFPatient-Specific Whole-Body Attenuation Correction Maps from a CT System for Conjugate-View-Based Activity Quantification: Method Development and Evaluation
No full textFrom fixed activities to personalized treatments in radionuclide therapy: lost in translation?
Get PDFInternational audienceno abstrac
MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative Lu-177 SPECT Applied for Dosimetry of Radiopharmaceutical Therapy
No full textMIRD pamphlet no. 26: Joint EANM/MIRD guidelines for quantitative 177Lu SPECT applied for dosimetry of radiopharmaceutical therapy
No full textThe accuracy of absorbed dose calculations in personalized internal radionuclide therapy is directly related to the accuracy of the activity (or activity concentration) estimates obtained at each of the imaging time points. MIRD Pamphlet no. 23 presented a general overview of methods that are required for quantitative SPECT imaging. The present document is next in a series of isotope-specific guidelines and recommendations that follow the general information that was provided in MIRD 23. This paper focuses on Lu-177 (lutetium) and its application in radiopharmaceutical therapy
From fixed activities to personalized treatments in radionuclide therapy: lost in translation?
No full text
